• SENSEX 80,599.91
    -585.67 (--0.72%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Valiant Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 79218.0
  • ISIN : INE0JWS01017
90.19 -1 (-1.57%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    88.41

  • Today’s High

    94.00

  • Open

    94.00

  • Perv Close

    91.63

  • 52W Low

    69.84

  • 52W High

    127.98

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    489.84

  • Div & Yield %

    0.00

  • Book Value(₹)

    58.15

  • Debt-Equity Ratio

    -1.57

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.41

  • Mar.Cap (₹Cr.)

    489.84

  • RONW (%)

    -1.71

  • ROCE (%)

    -1.63

Score Board

  • Equity (₹ in Cr.)

    54.31

  • BV (₹)

    58.20

  • Sales( ₹ in Cr.)

    133.36

  • NP (in Cr.)

    -2.15

  • NP Var(%)

    25.0

  • Div%

    0.0

  • CPS (₹)

    0.00

  • EPS (₹)

    -0.40

  • Traded Value (₹ in Lakhs)

    491.20

  • 52 Week High

    127.98

  • 52 Week Low

    69.84

  • Price BSE

    90.0

  • Price NSE

    90.00

  • Market Capital( in Cr.)

    491.20

  • P/C Ratio

    -3,891.80

  • P/E Ratio

    -227.30

  • Price Vs.BV

    -0.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 182.05 333.91 291.52 182.37 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 182.05 333.91 291.52 182.37 - -
Other Income 9.68 4.86 1.95 1.41 - -
Stock Adjustments 1.14 0.24 1.97 0.13 - -
Total Income 192.87 339.01 295.44 183.91 - -
EXPENDITURE :            
Raw Materials 168.66 276.76 236.19 120.53 - -
Power and Fuel Cost 8.33 7.37 4.38 3.17 - -
Employee Cost 4.31 4.61 3.06 2.71 - -
Other Manufacturing Expenses 6.07 4.86 3.70 3.55 - -
Selling and Administration Expenses 2.76 4.09 2.76 2.25 - -
Miscellaneous Expenses 1.46 1.37 1.09 0.29 - -
Employee Benefit Expenses 4.31 4.61 3.06 2.71 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 191.59 299.06 251.18 132.50 - -
Operating Profit 1.28 39.95 44.26 51.41 - -
Interest 0.08 0.25 0.07 1.78 - -
Gross Profit 1.20 39.70 44.19 49.63 - -
Depreciation 1.95 1.56 2.49 2.61 - -
Profit Before Tax -0.75 38.14 41.70 47.02 - -
Current Tax -0.98 8.80 14.47 16.46 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax -0.11 0.34 -0.26 -0.03 - -
Reported Net Profit 0.34 29.00 27.50 30.59 - -
Extraordinary Items 3.20 0.00 0.03 0.00 - -
Adjusted Net Profit -2.86 29.00 27.47 30.59 - -
Adjustment below Net Profit 0.18 0.03 -48.92 19.37 - -
P & L Balance brought forward 51.59 22.56 78.08 28.12 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 34.10 0.00 - -
P & L Balance carried down 52.11 51.59 22.56 78.08 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 0.08 8.91 16.89 29.14 - -
Earnings Per Share(Adj)-Unit Curr 0.07 - - - - -
Book Value 54.52 30.86 43.89 84.36 - -
Book Value(Adj)-Unit Curr 50.60 - - - - -

Shareholding Pattern

  • Promoter Group

    74.94%

  • Public Share Holding

    25.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,211,000 28.10 12,211,000 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 32,561,000 74.94 32,561,000 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 275,568 0.63 275,568 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 200,000 0.46 200,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 475,568 1.09 475,568 3
2] Non Institution
Bodies Corporate 2,332,711 5.37 2,332,711 68
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 73,398 0.17 73,398 90
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 565,571 1.30 565,571 537
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,105,530 7.15 3,105,530 41
Individuals holding nominal share capital up to Rs. 1 lakh 4,302,440 9.90 4,302,440 13,676
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,413,432 23.97 10,413,432 14,421
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 43,450,000 100.00 43,450,000 14,432

Company Background

Valiant Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Valiant Laboratories Ltd
  • BSE Code : 79218.0
  • ISIN : INE0JWS01017

  • Incorporation Year

    2021

  • Registered Office

    104 Udyog Kshetra Mulund
    Goregaon Link Rd Mulund West, Mumbai,
    Maharashtra-400080

  • Telephone

    +91 22 49712001

  • FAX

  • Chairman

  • Managing Director

    Santosh S. Vora

  • Company Secretary

    Akshay Gangurde

  • Auditor

    Raman S Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Valiant Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Valiant Laborato 90.44 191.73 182.05 -226.10 -1.68
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10